Zufar Mulyukov
Zufar Mulyukov
Email verificata su novartis.com
Titolo
Citata da
Citata da
Anno
Efficiency of database search for identification of mutated and modified proteins via mass spectrometry
PA Pevzner, Z Mulyukov, V Dancik, CL Tang
Genome research 11 (2), 290-299, 2001
1862001
Automatic pathway building in biological association networks
A Yuryev, Z Mulyukov, E Kotelnikova, S Maslov, S Egorov, A Nikitin, ...
BMC bioinformatics 7 (1), 1-13, 2006
1172006
Ionization, dissociation, and level shifts of H 2+ in a strong dc or low-frequency ac field
Z Mulyukov, M Pont, R Shakeshaft
Physical Review A 54 (5), 4299, 1996
791996
EULER-PCR: finishing experiments for repeat resolution
Z Mulyukov, PA Pevzner
Biocomputing 2002, 199-210, 2001
222001
A plateau in high-order harmonic generation for a two-level atom
VP Krainov, ZS Mulyukov
Laser Phys 4, 544, 1994
141994
Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration
F Grassmann, S Harsch, C Brandl, C Kiel, P Nrnberg, MR Toliat, ...
JAMA ophthalmology 137 (8), 867-876, 2019
102019
Breakup of H 2+ by one photon in the presence of a strong dc field
Z Mulyukov, R Shakeshaft
Physical Review A 63 (5), 053404, 2001
102001
Neovascular Age‐Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect
Z Mulyukov, S Weber, E Pigeolet, A Clemens, T Lehr, A Racine
CPT: pharmacometrics & systems pharmacology 7 (10), 660-669, 2018
42018
Acceleration of electrons under the ionization of atoms by focused laser pulse radiation
VP Krainov, ZS Mulyukov
Laser Phys 4, 509, 1994
41994
Comparison of the efficacy of brolucizumab with natural disease progression in wet AMD using clinical data from the Phase III HAWK and HARRIER trials and modelled placebo data
H Agostini, Z Mulyukov, M Tsilimbaris, P Calvo, F Bucher, D Gaucher, ...
Current eye research 45 (10), 1298-1301, 2020
32020
A Quasistationary State in a Zero-Range Potential Well Perturbed by a Superstrong Electric Field
VP Krainov, ZS Mulyukov
LASER PHYSICS 3 (3), 756-758, 1993
21993
Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modelling approach
Y Xiong, E Pigeolet, Z Mulyukov, P Margaron, A Racine, A Clemens
Contemporary clinical trials 80, 34-39, 2019
12019
Part I. Break Up of the Hydrogen Molecular Ion by an Electric Field. Part II. Protein Identification via Mass Spectrometry
Z Mulyukov
University of Southern California, 2000
12000
A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis
U Schmidt-Erfurth, Z Mulyukov, BSS Gerendas, P Margaron, D Lorand, ...
Investigative Ophthalmology & Visual Science 61 (7), 1159-1159, 2020
2020
Pharmacokinetics and Pharmacodynamics of AFQ056 in Parkinson Disease-Levodopa Induced Dyskinesia (PD-LID) treatment
Z Mulyukov, G Graham, I Paule, E Pigeolet
2014
ONE-PHOTON BREAKUP OF H IN A STRONG DC FIELD
Z MULYUKOV, R SHAKESHAFT
Super-Intense Laser-Atom Physics 12, 189, 2001
2001
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–16